Hydroxyurea Optimisation in Sickle Cell Disease
NCT07543289
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Hydroxyurea (HU)
Sponsor
Ochuko Orherhe
Collaborators
[object Object]
[object Object]
[object Object]